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Glutamate receptors play an important role in the function of astrocytes. Among their
tasks is the regulation of gliotransmission, gene expression and exocytosis of the
tissue-type plasminogen activator (tPA), which has an enhancing effect on N-methyl-
D-aspartate (NMDA) receptors and thus prevent over-excitation of neighboring neurons.
The kainate receptor GluK2, which is expressed in neurons and astrocytes, is under tight
regulation of the PI3-kinase SGK pathway as shown in neurons. SGK1 targets include
N-myc downstream-regulated genes (NDRGs) 1 and 2 (NDRG1, NDRG2), proteins with
elusive function. In the present study, we analyzed the effects of SGK1, NDRG1, and
NDRG2 on GluK2 current amplitude and plasma membrane localization in astrocytes
and heterologous expression. We demonstrate that NDRG1 and NDRG2 themselves
have no effect on GluK2 current amplitudes in heterologous expressed ion channels.
However, when NDRG2 is coexpressed with GluK2 and SGK1, the stimulating effect of
SGK1 on GluK2 is suppressed both in heterologous expression and in astrocytes. Here,
we reveal a new negative feedback mechanism, whereby GluK2 stimulation by SGK1 is
regulated by parallel phosphorylation of NDRG2. This regulation of GluK2 by SGK1 and
NDRG2 in astrocytes may play an important role in gliotransmission, modulation of gene
expression and regulation of exocytosis of tPA.
Keywords: glutamate receptor, GluR6, trafficking, phosphorylation, regulation, fluorescence, immuno-
cytochemistry, line plot
Introduction
Ionotropic glutamate receptors play an important role in the function of astrocytes, the most
abundant glial cells in the brain (Cornell-Bell et al., 1990; Kim et al., 1994; Casse et al., 2012).
These receptors are classified into three types and are named according to their selective agonists
N-methyl-D-aspartate (NMDA), γ-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA), and kainate.
Expression of kainate receptor subunits (GluK) was examined in various animal models,
and various brain regions in astrocytes (García-Barcina and Matute, 1996; Paschen et al.,
1996; Brand-Schieber et al., 2004). Kainate depolarizes primary astrocytes from the brain of rats
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and moreover, increases the intracellular calcium concentration
in astrocytes of hippocampal slices (Cornell-Bell et al., 1990;
McNaughton and Hunt, 1992; Kim et al., 1994). Since kainate
receptors are partially Ca2+-permeable (Paschen et al., 1996;
Lowe et al., 1997; Bernard et al., 1999), important regulatory
mechanisms can be activated through activation of GluK
receptors and the resulting influx of Ca2+ ions. The increase in
intracellular Ca2+ after activation of GluK receptors by kainate
(Cornell-Bell et al., 1990; Kim et al., 1994; Liu et al., 2004)
triggers Ca2+ waves within the astrocytic syncytium andmay lead
to release of gliotransmitters, e.g., glutamate or the tissue-type
plasminogen activator (tPA) from astrocytes (Liu et al., 2004;
Mothet et al., 2005; Casse et al., 2012). The released glutamate
has further effects on neighboring hippocampal neurons by
triggering a slow, transient current, which in turn can activate
NMDA receptors (Angulo et al., 2004; Fellin et al., 2004) or
by activating GluK5-containing kainate receptors on adjacent
interneurons and thus increases their inhibitory postsynaptic
currents (Rodríguez-Moreno and Lerma, 1998; Liu et al.,
2004). Thus, kainate receptors in astrocytes serve as sensors
for extracellular glutamate in astrocytes thereby preventing
excitotoxicity.
Due to their key functions glutamate receptors like NMDA
receptors or kainate receptors are subject to very tight regulation.
The GluK2 subunit is functionally modulated by the serum-
and glucocorticoid-inducible kinase 1. Expression of SGK1
in the human brain has been shown both in neurons and
in oligodendrocytes (Webster et al., 1993; Imaizumi et al.,
1994; Wärntges et al., 2002). The expression in astrocytes is
currently debated, as there are insufficient, valid direct protein
observations for these cells (Wärntges et al., 2002; Stichel et al.,
2005; Slezak et al., 2013; Wu et al., 2013). SGK1 transcription
is stimulated by a wide variety of hormones including
glucocorticoids and mineralocorticoids as well as by cell stress,
such as cell shrinkage, increase of cytosolic Ca2+ activity and
by cellular energy depletion (Webster et al., 1993; Brennan
and Fuller, 2000; Ullrich et al., 2005). SGK1 phosphorylates
target proteins at the classical SGK1 consensus sequence R-
X-R-X-X-(S/T)-h, with X being a random amino acid, R an
arginine, S/T serine or threonine and an hydrophobic amino acid
(Kobayashi and Cohen, 1999). As shown by electrophysiological
techniques and immunohistochemical studies on Xenopus
laevis oocytes and hippocampal neurons SGK1 increases
GluK2 cell membrane protein abundance and thus glutamate-
induced current amplitude (Strutz-Seebohm et al., 2005). The
disclosed modulation of GluK2 activity is due to indirect
phosphorylation of the iGluR via the activation of a hitherto
elusive signaling cascade that results in an increase of
the plasma membrane expression of the iGluR. However,
there are also proteins that are directly phosphorylated by
SGK1. These proteins include two representatives of the
N-myc downstream-regulated gene (NDRG) protein family,
NDRG1 and NDRG2 (Murray et al., 2004; Okuda et al.,
2008).
The NDRG protein family consists of four members
(NDRG1-4). All NDRG proteins were detected in the central
nervous system. NDRG3 and NDRG4 are ubiquitously
expressed, whereas NDRG1 and NDRG2 are only detected
in oligodendrocytes and astrocytes (Okuda et al., 2008). NDRG1
has five phosphorylation sites for SGK1 (T328, S330, T346, and
T356, T366). NDRG2 has three phosphorylation sites for SGK1,
which are equivalent to the first three sites in NDRG1 (T330,
S332, and T348; Murray et al., 2004).
NDRG2 is expressed in many parts of the brain, including
the hippocampus (Nichols, 2003; Shen et al., 2008). The protein
expression in adult animals is limited to astrocytes in these
brain areas (Nichols, 2003; Okuda et al., 2008; Flügge et al.,
2014). Like SGK1, NDRG2 is modulated by glucocorticoids at
the transcriptional level. Exposure to dexamethasone (Dexa)
leads to increased NDRG2 mRNA in astrocytes (Nichols,
2003; Liu et al., 2011; Takahashi et al., 2011). Currently, any
knowledge of the precise function of NDRG2 in astrocytes
is limited. It was suggested that NDRG2 may be important
for neurogenesis (Nichols, 2003; Shen et al., 2008; Liu et al.,
2011), cell proliferation and differentiation within murine
brains (Shen et al., 2008; Liu et al., 2011; Takeichi et al.,
2011). NDRG2 has also distinct effects on ion channels
(Wielpütz et al., 2007; Li et al., 2011). Furthermore, NDRG2
modulates the half-life of the Na+/K+-ATPase (Li et al.,
2011).
The aim of this study was to gain insight into the regulatory
mechanism how the proteins NDRG1 and NDRG2, which
are directly phosphorylated by SGK1, influence the SGK1-
activated signaling cascade that ultimately leads to an increase in
membrane expression of GluK2.
Materials and Methods
cDNAs and Mutagenesis of Vector Constructs
The following cDNAs were used: GluK2/pSGEM,
GluK2/pSGEM-enhanced green fluorescent protein (EGFP),
SGK1/pGHJ, NDRG1/pCMV-Sport6, NDRG2/pCMV-
Sport6. The point mutations were introduced into mouse
NDRG2/pCMV-Sport6 by using the QuickChange Lightning
Site-Directed Mutagenesis Kit (Agilent Technologies, Santa
Clara, CA, USA). Success of mutagenesis was verified by
sequencing.
Synthesis of cRNA
Template DNA was linearized with an appropriate restriction
enzyme. cRNA was synthesized from 1 µg linearized DNA
using an in vitro transcription kit (mMessage mMachine SP6
or T7 kit—Ambion, Life Technologies, Darmstadt, Germany).
Concentrations of cRNA were examined by photospectrometry
(NanoDrop ND-100) and the quality of the transcript was
verified by agarose gel electrophoresis.
Heterologous Expression in Xenopus laevis
Oocytes
cRNA (GluK2 4 ng, SGK1 6 ng, NDRG2 6 ng) was injected into
stage V–VI Xenopus oocytes, provided by Ecocyte Bioscience
(Castrop-Rauxel, Germany). All measurements were performed
5–6 days after injection of cRNA. Oocytes were incubated at
17–18◦C.
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Electrophysiological Recordings
The two-electrode voltage clamp technique (Goldin, 2006) was
used to record whole cell currents in Xenopus oocytes at room
temperature (22–23◦C). Data were acquired and analyzed using
pCLAMP 8.0 software (Axon Instruments, Sunnyvale, CA, USA).
Data analyses were done with pClamp/Clampex software 8.0
(Axon Inc., CA, USA) and Prism 6.1 software (GraphPad
Software, San Diego, CA, USA). For voltage clamp experiments,
agonist solutions were prepared in ND-96 buffer (mM: NaCl
96, CaCl2 1.8, KCl 2.0, MgCl2 1.0 and HEPES–NaOH 5, pH
7.2 with NaOH). Current and voltage electrodes were filled
with 3 M KCl and had resistances of 0.5–1.2 MΩ. The oocytes
were held at −80 mV and agonist (300 µM glutamate; Sigma-
Aldrich, Schnelldorf, Germany) was superfused for 20 s at a
flow rate of 10–14 ml min−1. Prior to agonist application, the
oocytes were incubated for 8 min in concanavalin A (ConA)
to prevent GluK2 desensitization. Data are provided as means
± SEM, n represents the number of oocytes investigated.
All experiments were repeated with at least three batches of
oocytes; in all repetitions qualitatively similar data were obtained.
Data were tested for significance using Student’s t-test and
ANOVA, and results with p < 0.05 were considered statistically
significant.
Preparation of Cell Surface Proteins and
Cytosolic Proteins out of Xenopus Oocytes
To identify the fraction of receptor protein inserted in the plasma
membrane, surface proteins were tagged with biotinylated ConA
and isolated by streptavidin-sepharose-mediated precipitation
of the biotinyl-ConA-protein complex as previously described
by Strutz-Seebohm et al. (2003). For determination of cytosolic
proteins, intact oocytes were homogenized with a teflon pestle in
H-buffer (25 µl/oocyte; 100 mMNaCl, 20 mM Tris-HCl, pH 7.4,
1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride plus a
mixture of proteinase inhibitors [CompleteTM tablets, Roche
Applied Science, Penzberg, Germany]). After centrifugation for
2 min at 16,000×g, the supernatants were supplemented with
9 µl of SDS-PAGE loading buffer (0.8 M ß-mercaptoethanol, 6%
SDS, 20% glycerol, 25 mM Tris-HCl, pH 6.8, 0.1% bromphenol
blue).
Gel Electrophoresis and Western Blotting
Proteins from homogenized oocytes were separated by SDS gel
electrophoresis and transferred to nitrocellulose membranes.
Blots were blocked in 1× PBS containing 1% RotiBlock
(Roth, Karlsruhe, Germany) for at least 2 h at room
temperature. For the detection of GluK2, primary goat
polyclonal IgG anti-GluK2 antibody (1 µg µl−1) and secondary
horseradish peroxidase-conjugated rabbit anti-goat antibody
(1:1000 dilution) were used. For verification of protein levels,
Ponceau Red staining was performed. For the detection of
NDRG2, primary goat polyclonal IgG anti-NDRG2 antibody
(1 µg µl−1) and secondary horseradish-peroxidase-conjugated
rabbit anti-goat antibody (1:1000 dilution) were used. For
verification of protein levels, Ponceau Red staining was
performed.
Confocal Microscopy of Oocytes
C-terminal EGFP-tagged ion channels expressed in Xenopus
oocytes were imaged using a TCS SP2 AOBS confocal
microscope (Leica Microsystems, Wetzlar, Germany). EGFP was
excited at 488 nm, and fluorescence was detected between
500 and 600 nm in combination with 20× objective (HC
PL APO Ibd.BL 20×/0.7 water). The data were analyzed
with ImageJ (U.S. National Institutes of Health, Bethesda,
MD, USA).
Primary Hippocampal Cell Culture
The studies have been performed under the terms of the
German animal protection law. Newborn wild type Wistar
rats of postnatal day 0–2 (P0–P2) were used for cultivation
of primary rat hippocampal astrocytes. Primary hippocampal
astrocytes were prepared according to a similar protocol as
described by Seebohm et al. (2012). In brief, the hippocampi
of P0–P2 new-born Wistar rats were minced in ice cold
MPBS+/+ (modified phosphate-buffered saline supplemented
with 0.25 mM CaCl2, 5.8 mM MgCl2, 10 mM HEPES,
1 mM sodium pyruvate, 6 µg/ml DNaseI, 1 mg/mL bovine
serum albumin (BSA), 10 mM glucose, 25 U/mL penicillin,
25 µg/ml, streptomycin, 2 mM glutamine, 5 mg/mL phenol
red, 4 mM NaOH) and digested with 10% trypsin in
MPBS−/− (MPBS+/+ without CaCl2 and MgCl2) for 7 min
while shaking at 37◦C and 750 rpm. After removing of
the remaining tissue, the supernatant (containing dissociated
cells) was diluted two-fold with RPMI/10% fetal calf serum
[FCS; 2 mM glutamine, 10% FCS, 25 U/mL penicillin,
25 µg/ml, streptomycin, 0.00375% insulin, 5 mM glucose,
10 mM HEPES, in RPMI 1640 (PAA)] to terminate digestion.
Residual tissue pieces were dissociated by trituration in
MPBS−/− with pipette tips three times. The cells were
collected by centrifuging at 500×g for 10 min. The cells
were dissociated in RPMI/10% FCS, seeded at a density
of 125,000 cells per 12 mm collagen-coated glass cover
slip and cultivated at 37◦C and 5% CO2. For preparation
of astrocyte enriched cultures, the medium was retrieved
after 1.5 h. The following day, the media was exchanged
against neurobasal medium (Invitrogen, Darmstadt, Germany)
containing B-27 serum-free supplement (Invitrogen; 1× B27,
2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin
in neurobasal medium). Every second to third day the
media was exchanged against fresh pre-incubated medium.
On day three and five of cultivation, transfection of control
siRNA (sequence: UAGCGACUAAACACAUCAA; Thermo
Scientific, Schwerte, Germany) or a siRNA pool against
NDRG2 (ACCCAAACGUCCAGCGAUA; CGUUGAAGGUCU
UGUUCUC; UUUCAAGUACUUCGUGCAA; GCAUACAU
UCUGUCACGAU; Thermo Scientific, Schwerte, Germany) was
performed with Effectene (Qiagen, Hilden, Germany). The cells
were used for experiments after 9 days in vitro. The media was
removed and fresh neurobasal medium without B-27 was added
to the cells 4 h prior to stimulations of SGK1 with dexamethasone
(1 µM; Sigma-Aldrich, Schnelldorf, Germany). Finally, the cells
were fixed with 4% paraformaldehyde in PBS or harvested for
preparation of intracellular proteins.
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Preparation of Intracellular Proteins Out
of Astrocyte Enriched Cultures
To determine expression levels of SGK1 and NDRG2, astrocyte
enriched cultures were prepared and treated with siRNA
and/or Dexa as described above. Control cells were treated
with Effectene alone. For lysis of hippocampal cells, the 3.5-cm
dish plate was washed with 1× PBS to remove residual media.
Then, 500 µl of ice-cold 1× PBS/3.5 cm dish was added and
the cells were mechanically released, followed by centrifugation
at 4◦C for 10 min at 14,000×g. 20 µl of 1× cell lysis buffer
(Cell Signaling Technology, Danvers, MA, USA) was added
and the cells incubated on ice for 5 min. After centrifugation at
4◦C for 10 min at 14,000×g, the supernatant was removed and
stored at −80◦C until needed. Prior to gel electrophoresis and
Western blotting, a protein assay (DC Protein Assay, Bio-Rad
Laboratories, Munich, Germany) was performed to determine
the total protein concentrations. For Western blotting, 2–5 µg
of total protein was applied per lane. For the detection of
NDRG2, primary goat polyclonal IgG anti-NDRG2 antibody
(1 µg µl−1) and secondary horseradish-peroxidase-conjugated
rabbit anti-goat antibody (1:1000 dilution) were used. For
the detection of SGK1, primary mouse monoclonal IgG2b
anti-SGK1 antibody (1 µg µl−1) and secondary horseradish-
peroxidase-conjugated sheep anti-mouse antibody (1:1000
dilution) were used. The specificity of primary antibodies was
tested by Western blot by using blocking peptides for NDRG2
(#sc-19468 P, Santa Cruz, Heidelberg, Germany) and SGK
(sc-28338 P, Santa Cruz, Heidelberg, Germany) according
to manufactures protocols. For verification of protein levels,
Ponceau Red staining was performed as well as detection of
calnexin (primary antibody: 1 µg µl−1; secondary antibody:
1:1000 dilution).
Immunocytochemistry
For immunocytochemistry, mixed hippocampal cultures were
fixed with 4% paraformaldehyde. The primary cells were
incubated with 0.3% Triton X-100 in PBS for 10 min. Thereafter,
cells were washed three times with PBS and unspecific binding
sites were blocked with 5% goat-serum in PBS for 30 min.
Further the cells were incubated with primary antibodies
overnight at 4◦C (rabbit anti-glial fibrillary acidic protein
(GFAP); goat anti-GluK2; mouse anti-SGK1; goat anti-NDRG2).
The samples were then reacted with secondary antibodies for
2 h at room temperature (anti-rabbit AlexaFluor594; anti-mouse
AlexaFluor488; anti-goat AlexaFluor488). Nuclei were stained
with DAPI (1 µg/ml; #D9542, Sigma-Aldrich, Schnelldorf,
Germany). Finally, cultures were rinsed in PBS and coverslipped
in fluoromount (#F4680, Sigma-Aldrich, Schnelldorf, Germany).
Samples were imaged using an inverted Zeiss Cell Observer
fluorescence microscope equipped with the respective filter
sets, an ApoTome and an Axiocam MRm in combination
with Zeiss 63× oil immersion lens (Plan-Apochromat, 63×/1.4
Oil DICII, Zeiss, Oberkochen, Germany). Overlay and analysis
were performed with AxioVision software (Zeiss, Oberkochen,
Germany).
Hippocampal mixed and astrocyte enriched cultures were
stained with GFAP or Neurofilament N specific for astrocytes
and neurons, respectively to provide an overview of culture
composition (Supplementary Figure S1).
Relative Abundance of GluK2 in Astrocytes
Determined by Fluorescence Microscopy
The images were analyzed using AxioVision (Zeiss, Oberkochen,
Germany) and Prism software (GraphPad Software, San Diego,
CA, USA). After scanning an astrocyte using an oil immersion
objective (63×), a fluorescence profile omitting the nucleus
within the cell soma was created. The fluorescence intensities
within such a profile were normalized to the highest value.
The increase of the fluorescence intensity within the first
micrometer of the cell was described by a linear equation,
and the regression coefficient was determined. To investigate
changes in the localization of the glutamate receptor at the
astrocyte membrane, the determined regression coefficients were
compared under different conditions. If the GluK2 fluorescence
increases rapidly within the first micrometer of the cell, i.e., at the
membrane, the regression coefficient is correspondingly larger,
indicating an increase in the number of receptors in close vicinity
to the astrocyte membrane.
Antibodies Used for Western Blotting and
Immunocytochemistry
The following primary antibodies were used forWestern blotting
and immunostaining:
goat anti-GluK2 #sc-7618 Santa Cruz Heidelberg,
Germany
goat anti-NDRG2 #sc-19468 Santa Cruz Heidelberg,
Germany
mouse anti-SGK1 #sc-28338 Santa Cruz Heidelberg,
Germany
rabbit anti-Calnexin #sc-11397 Santa Cruz Heidelberg,
Germany
rabbit anti-GFAP #G9269 Sigma-Aldrich, Schnelldorf,
Germany
rabbit anti-MAP2 #M3696 Sigma-Aldrich, Schnelldorf,
Germany
The following secondary antibodies were used for Western
blotting:
HRP-conjugated rabbit #A5420 Sigma-Aldrich,
anti-goat Schnelldorf, Germany
HRP-conjugated donkey #NA934 GE Healthcare,
anti-rabbit Solingen, Germany
HRP-conjugated #NA931 GE Healthcare,
sheep anti-mouse Solingen, Germany
The following secondary antibodies were used for
immunocytochemistry:
AlexaFluor594 goat #A11012 Life Technologies,
anti-rabbit Darmstadt, Germany
AlexaFluor488 donkey #A21202 Life Technologies,
anti-mouse Darmstadt, Germany
AlexaFluor488 rabbit #A11078 Life Technologies,
anti-goat Darmstadt, Germany
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Results
NDRG2 Suppressed the GluK2
Current-Stimulating Effect of SGK1 in a
Concentration-Dependent Manner
The present study explored the modulatory effect of NDRG2
on the SGK1-activated signaling cascade, which leads to a
change in membrane expression of GluK2. For this purpose, the
channel was heterologously expressed in Xenopus laevis oocytes,
with or without SGK1 and/or NDRG2. Glutamate-induced
current amplitudes were studied by two-electrode voltage clamp
measurements. As shown in Figure 1 application of glutamate
induced a strong current in Xenopus oocytes overexpressing
GluK2. Expression of SGK1 in addition to GluK2 significantly
increased the GluK2 current. By contrast, coexpression of
GluK2 with NDRG2 did not alter the glutamate-induced current
amplitude compared with GluK2 alone. Thus, the stimulating
effect of SGK1 on GluK2 was not detectable when GluK2
was coexpressed with SGK1 and NDRG2 (Figures 1A,B). As
illustrated in Figure 1C, the suppressive effect of NDRG2
was dependent on the amount of NDRG2 cRNA injected and
statistically significant at 0.6 and 6 ng NDRG2, but not at 0.06 ng.
The expression of NDRG2 proteins after injection of different
amounts of cRNA was detected by Western blot (Figure 1D).
A clear protein band can be observed by usage of 0.6 and
6 ng NDRG2 cRNA, whereas no expression of NDRG2 can be
observed at injection of 0.06 ng NDRG2 cRNA.
Suppressive Effect of NDRG2 on
SGK1-Dependent Modulation of GluK2
Membrane Expression
The increase of GluK2 currents following coexpression of SGK1
resulted from an enhanced abundance in the plasma membrane
(Strutz-Seebohm et al., 2005). Thus, chemiluminescence and
FIGURE 1 | Suppression of the GluK2-stimulating effect of SGK1 by NDRG2. (A) Representative current traces measured in Xenopus oocytes in response to
super fusion with 300 µM glutamate. Black bars above the current traces indicate the application of glutamate (arrows indicate start and stop of application). All
currents were measured at −80 mV and after pretreatment of oocytes with ConA to minimize desensitization. (B) GluK2 current amplitudes in oocytes expressing
GluK2 (n = 106), GluK2 + SGK1 (n = 85), GluK2 + NDRG2 (n = 73) and GluK2 + SGK1 + NDRG2 (n = 69) were measured and are shown normalized to GluK2
currents. Significant differences are indicated by ∗∗∗∗p < 0.0001. (C) GluK2 current amplitudes in oocytes expressing GluK2 (n = 15), GluK2 + SGK1 (n = 11), GluK2
+ NDRG2, and GluK2 + SGK1 + NDRG2 at different amounts of NDRG2 (0.06, 0.6 and 6 ng) and same amount of SGK1 (6 ng) were measured and are shown
normalized to GluK2 currents (n = 11–14). Significant differences are indicated by ∗∗p < 0.01, ∗p < 0.05, n.s. = not significant. (D) Exemplary Western blot of
cytosolic expressed NDRG2 after injection of the corresponding amount of cRNAs and an expression time of 6 days. Oocytes were homogenized. Samples including
controls from uninjected oocytes were separated on an SDS gel, blotted onto a nitrocellulose membrane and probed with an anti-NDRG2 antibody. The NDRG2
protein has an apparent molecular mass of ∼42 kDa.
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FIGURE 2 | Suppressive effect of NDRG2 on SGK1-dependent modulation of GluK2 membrane expression. (A) Representative Western blot demonstrating
the suppressive effect of NDRG2 on SGK1-dependent modulation of GluK2 membrane expression. Glycosylated plasma membrane proteins expressed in oocytes
were labeled with biotinylated concanavalin A (ConA). Oocytes were homogenized and plasma membrane proteins were streptavidin-precipitated. Samples including
controls from uninjected oocytes were separated on an SDS gel, blotted, onto a nitrocellulose membrane and probed with an anti-GluK2 antibody. The double band
might represent different glycosylation forms of the GluK2 protein (Strutz-Seebohm et al., 2006). The GluK2 protein has an apparent molecular mass of ∼118 kDa.
(B) Bar graph showing relative abundance of GluK2 plasma membrane protein (n = 4). The band intensity was quantified by arithmetic analysis using the software
ImageJ. (C) Imaging of enhanced green fluorescent protein (EGFP)-GluK2 expression in Xenopus oocytes at different conditions of proteins expressed. Confocal
laser-scanning microscopy of control oocytes and oocytes expressing GluK2-EGFP, GluK2-EGFP + SGK1, GluK2-EGFP + NDRG2 or GluK2-EGFP + SGK1 +
NDRG2. Representative images are presented in which the optical slice approximately bisects the oocyte. Scale bars (white) indicate 150 µm. (D) Bar graph
showing normalized (to GluK2-EGFP alone) mean signal intensities of GluK2-EGFP in oocytes at different constellations of injected cRNA (n = 11–51). The intensity
was quantified by arithmetic analysis using the software ImageJ. Significant differences are indicated by ∗∗∗p < 0.0001, n.s. = not significant. (E) GluK2-EGFP
current amplitudes in oocytes expressing GluK2-EGFP (n = 17), GluK2-EGFP + SGK1 (n = 13), GluK2-EGFP + NDRG2 (n = 14), and GluK2-EGFP + SGK1 + NDRG2
(n = 12) were measured and are shown normalized to GluK2-EGFP currents. All currents were measured at −80 mV and after pretreatment of oocytes with ConA to
minimize desensitization. Significant differences from current amplitudes in oocytes are indicated by ∗∗p < 0.01, n.s. = not significant.
a C-terminal EGFP-tagged GluK2 were used to quantify
GluK2 protein abundance in the cell membrane of Xenopus
laevis oocytes expressing GluK2 with or without SGK1 and/or
NDRG2. As shown in Figures 2A,B, the protein abundance
of GluK2 was significantly enhanced in Xenopus oocytes
expressing GluK2 together with SGK1 compared with GluK2
alone. No significant effect on GluK2 protein abundance was
observed following coexpression of NDRG2. The stimulating
effect of SGK1 on GluK2 membrane expression was also not
detectable when GluK2 was coexpressed with SGK1 andNDRG2.
The same observations were made with the EGFP-tagged
GluK2 protein (Figures 2C,D). Coexpression of GluK2-EGFP
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FIGURE 3 | NDRG1 does not affect SGK1-dependent modulation of GluK2 membrane expression. (A) Representative current traces measured in Xenopus
oocytes in response to super fusion with 300 µM glutamate. Black bars above the current traces indicate the application of glutamate (arrows indicate start and stop
of application). All currents were measured at −80 mV and after pretreatment of oocytes with ConA to minimize desensitization. GluK2 current amplitudes in oocytes
expressing GluK2 (n = 106), GluK2 + SGK1 (n = 85), GluK2 + NDRG2 (n = 19) and GluK2 + SGK1 + NDRG2 (n = 16) were measured and are shown normalized to
GluK2 currents (bar graph). Significant differences from current amplitudes in oocytes are indicated by ∗∗∗∗p < 0.0001. (B) Representative Western blot
demonstrating no effect of NDRG1 on SGK1-dependent modulation of GluK2 membrane expression. Glycosylated plasma membrane proteins expressed in oocytes
were labeled with biotinylated ConA. Oocytes were homogenized and plasma membrane proteins were streptavidin-precipitated. Samples including controls from
uninjected oocytes were separated on an SDS gel, blotted onto a nitrocellulose membrane and probed with an anti-GluK2 antibody. The GluK2 protein has an
apparent molecular mass of ∼118 kDa. Bar graph showing relative abundance of GluK2 plasma membrane protein (n = 4). The band intensity was quantified by
arithmetic analysis using the software ImageJ.
with SGK1 increased membrane fluorescence in GluK2-EGFP
expressing oocytes significantly. Expression of GluK2-EGFP in
addition to NDRG2 showed no effect on GluK2-EGFP protein
abundance. The stimulating effect of SGK1 on GluK2-EGFP
membrane expression was again abrogated following additional
coexpression of NDRG2. Properties of currents expressed
in oocytes and modulatory effects of the proteins SGK1
and NDRG2 were not affected by the C-terminal EGFP tag
(Figure 2E).
NDRG1 did not Modulate SGK1-Dependent
Stimulation of GluK2 Membrane Expression
As shown in Figure 3A, coexpression of NDRG1 tended to
slightly but not significantly increase the glutamate-induced
current amplitude in GluK2 expressing oocytes. Coexpression
of SGK1 significantly increased the glutamate-induced current
amplitude in GluK2 expressing oocytes. The effect was not
significantly augmented by additional coexpression of NDRG1
and correspond to the analysis of membrane expression of GluK2
in Xenopus laevis oocytes (Figure 3B).
NDRG2 Phosphorylation at -T330 is Required for
Suppressing the SGK1 Effect
To examine the hypothesis that NDRG2 phosphorylation may
be required for the suppressive effect on SGK1-dependent
modulation of GluK2, we generated NDRG2 point mutants at
the putative phosphorylation sites and studied the glutamate-
induced current amplitudes of GluK2. Uniform expression
of all NDRG2 mutants was verified in the Xenopus oocyte
system by Western blotting (Supplementary Figure S2). First, we
substituted the amino acids that are phosphorylated by SGK1
(Figure 4A), T330, S332, and T348, by neutral amino acids. The
results of these substitutions are shown in Figure 4B. NDRG2TAT
and NDRG2TSV show the same glutamate-induced current
amplitudes as wild type. Coexpression of these two mutants
did not significantly modulate the current amplitude in GluK2
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FIGURE 4 | Phosphorylation of NDRG2 is responsible for suppressing
of SGK1 effect. (A) NDRG2 amino acid sequence fragment with highlighted
SGK1 phosphorylation sites T330, S332, and T348. (B–D) GluK2 current
amplitudes in oocytes expressing GluK2 (n = 55), GluK2 + SGK1 (n = 67), and
GluK2 coexpressed with NDRG2 wild type or different mutants of NDRG2
containing point mutations at SGK1 phosphorylation sites (n = 13–48) with
and without SGK1 were measured and are shown normalized to GluK2
currents. Substitution of amino acids that are phosphorylated by SGK1 to
neutral amino acids (B), to phosphomimetic-amino acids (C) and
combinations of them (D) were investigated. All currents were measured at
−80 mV and after pretreatment of oocytes with ConA to minimize
desensitization. Significant differences are indicated by ∗∗∗∗p < 0.0001,
∗∗∗p < 0.001, n.s. = not significant.
expressing oocytes. No stimulating effect of SGK1 was observed
when GluK2 was expressed together with SGK1 and NDRG2TAT
or NDRG2TSV. Expression of GluK2 with NDRG2VST has no
effect on GluK2, whereas a stimulating effect is observed when
GluK2 is coexpressed with SGK1 and NDRG2VST. Further
experiments were done with phosphomimetically substituted
amino acids of the SGK1 phosphorylation sites on the NDRG2
protein (Figure 4C). Coexpression of GluK2 with NDRG2DDD
or NDRG2DST showed no differences in current amplitudes
compared to GluK2 alone. When SGK1 was coexpressed in both
conditions, no modulatory effect of SGK1 on GluK2 currents
could be observed. In addition, we performed experiments with
two other NDRG2 mutants, NDRG2TAV and NDRG2VDD. Here
again, no effect could be observed on GluK2 currents upon
coexpression of the NDRG2mutants (Figure 4D). GluK2 current
amplitudes were not stimulated when SGK1 was coexpressed
with NDRG2TAV. However, coexpression of GluK2 with SGK1
and NDRG2VDD showed significantly increased GluK2 current
amplitudes.
Expression of GluK2, SGK1, and NDRG2 in Rat
Hippocampal Astrocytes
To investigate the expression of GluK2, SGK1, and NDRG2
in cultured rat hippocampal astrocytes, we performed
immunocytochemical analyses using specific antibodies.
Double stains for GFAP, a commonly used astrocyte marker, and
GluK2 revealed colocalization of GluK2 and GFAP (Figure 5A).
The expression of GluK2 in astrocytes is not limited to a specific
region within the cell. Specific expression of SGK1 in astrocytes
was also confirmed by double staining of SGK1 and GFAP
(Figure 5B). Excessive expression of SGK1 was detected in
hippocampal astrocytes. NDRG2 was detected in hippocampal
astrocytes (Figure 5C), which was determined by colocalization
of GFAP and NDRG2 within the astrocyte. The specificity of the
commonly used GluK2 primary antibody has been shown before
Hirbec et al. (2005) and Kwon et al. (2007). The specificity of
NDRG2 and SGK primary antibodies was verified by Western
blot using blocking peptides.
Modulation of NDRG2 and SGK1 Protein Levels
in Cultured Hippocampal Astrocytes by
siRNA-Mediated Knockdown and
Dexamethasone-Stimulation of Protein
Expression
To investigate whether the modulation of SGK1-mediated
increase of membrane expression of GluK2 described above
for Xenopus oocytes also occurs in astrocytes we mimicked the
oocyte conditions in astrocytes by modulating the protein levels
of SGK1 and NDRG2.
First, the NDRG2 protein level in astrocytes was down-
regulated by a specific siRNA (Thermo Scientific, Schwerte,
Germany). As shown in Figure 6A, the NDRG2-specific siRNA
decreased the expression of NDRG2 significantly compared
to cells transfected with scrambled control siRNA or mock-
transfected cells. The expression level of SGK1was not influenced
by the transfection of NDRG2 siRNA and control siRNA
(Figure 6B). To enhance the protein level of SGK1 in astrocytes
we used the glucocorticoid dexamethasone. Dexamethasone
increased the cytosolic expression of SGK1 under various
conditions of transfection as presented in Figures 6C,D. Since
it is known that dexamethasone has a modulatory effect
on the expression level of NDRG2, we also determined the
level of NDRG2 in dexamethasone-treated cells. As shown
in Figure 6E, it could be verified that dexamethasone up-
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 October 2015 | Volume 9 | Article 387
Matschke et al. NDRG2 and SGK1 regulate GluK2
regulates the protein level of NDRG2 in astrocytes. NDRG2
siRNA was able to decrease the NDRG2 protein level compared
to control cells in both untreated and dexamethasone-treated
cells.
Alteration of GluK2 Distribution in Astrocytes
To determine whether the modulation of NDRG2 or SGK1
protein expression alters the membrane localization of GluK2
in astrocytes, we performed double staining for GFAP and
GluK2 (Figure 7A) and determined the relative intensity of
the fluorescence signal of GluK2 under different conditions
(Figures 7B,C). At the beginning and the end of the cell a
peak was apparent most likely reflecting the GluK2 protein at
the plasma membrane. Analysis of distribution of the relative
fluorescence signal was performed as described above. The
slope of the regression line of the plotted fluorescence within
the first micrometer of the cell was ascertained and compared
among the different conditions. siRNA-transfected but untreated
cells did not differ in progression of the fluorescence plot
(Figure 7D). Treatment of astrocytes with dexamethasone under
all conditions increased the signal intensity within the first
micrometer of the cell (Figures 7E–G). At each treatment
period, the signal intensity increased more strongly within
siRNA NDRG2-treated cells than in scrambled siRNA control-
transfected cells. As shown in Figure 7H, the values for
the slope of regression lines after transfection of siRNAs
but without dexamethasone treatment do not differ. Control
siRNA transfected cells exhibited a significant increase in the
regression coefficient after dexamethasone treatment for 12 and
20 h. Astrocytes treated with siRNA against NDRG2, showed
already after 20 min of treatment with dexamethasone a highly
significant increase in the regression coefficient in comparison to
untreated cells. After 12 and 20 h of dexamethasone treatment,
the slopes of the linear fitted lines were still significantly elevated
within the first micrometer of the cells. This was not the case
of the structural protein GFAP (Supplementary Figure S3).
Comparison of the two groups, siRNA control and siRNA
NDRG2, reveals a highly significant effect of the transfection
of siRNA NDRG2 on the regression coefficients and thus the
density of GluK2 at the membrane.
Discussion
NDRG2 Phosphorylated at T330 Suppresses the
SGK1-Activated Signaling Cascade that Leads to
an Increased Membrane Expression of GluK2 in a
Concentration Dependent Manner
The present results reveal a novel regulator of GluK2. In
Strutz-Seebohm et al. (2005) demonstrated that the serum- and
glucocorticoid dependent kinase SGK1 regulates the membrane
expression of GluK2. Here, we could show, that NDRG2 itself
does not directly modulate expression of the kainate receptor
GluK2 but suppresses the SGK1-activated increase in membrane
expression of GluK2 in Xenopus laevis oocytes. These findings
could be confirmed through Western blot analysis of membrane
preparations of Xenopus oocytes. In addition, the study of
membrane expression using EGFP-tagged fluorescent GluK2
matches with these results. Due to the absence of modulation by
NDRG2 alone, a direct regulation of GluK2 by NDRG2 can be
excluded. Thus, it can be concluded that NDRG2 intervenes with
the SGK1-activated signaling cascade, which leads to an increase
in membrane expression of GluK2. This effect of suppression
of the increase in membrane expression by NDRG2 might be
concentration-dependent. Upon injection of the same amount
of SGK1 and NDRG2 cRNA, suppression of the SGK1 effect
by NDRG2 can be observed. At a ratio of 10:1 (SGK1:NDRG2)
a tendency for increase of current amplitude by SGK1 can
be seen. However, a significant SGK1 effect on the GluK2
current amplitude was measured after injection of a 100-times
higher amount of SGK1-cRNA compared to NDRG2-cRNA.
It should be noted that no NDRG2 protein signal in Western
blot could be detected when using 0.06 ng NDRG2 cRNA. It
is possible that the protein amount was below the detection
limit, otherwise it cannot be excludes that NDRG2 was not
expressed in this condition. Nevertheless, a difference in the
characteristic of the suppressive effect of NDRG2 by usage
of 6 and 0.6 ng cRNA is present, which would still indicate
concentration dependence. Furthermore, the suppression
of increased membrane expression is dependent on the
phosphorylation of NDRG2 by SGK1. Our electrophysiological
measurements with different NDRG2 point mutants suggest
that phosphorylation of the first SGK1 phosphorylation site
of NDRG2, T330, seems to be essential for the suppressive
effect on the SGK1-mediated increase of membrane expression.
Mutant NDRG2 that is non-phosphorylatable at position T330
does not have the ability to intervene in the SGK1-activated
signaling cascade and thus does not suppress the increase in
membrane expression of GluK2 anymore. The exchange of
the second or third SGK1 phosphorylation sites of NDRG2
by neutral amino acids does not alter the suppression of the
SGK1 effect. The suppressive effect of T330-phosphorylated
NDRG2 could also be demonstrated with NDRG2 mutants by
performing a phosphomimetic substitution, i.e., inserting an
aspartic acid residue at either the first (NDRG2DST) or at all
three (NDRG2DDD) SGK1 phosphorylation sites. Deprotonated
aspartic acid fulfills the same function as a phosphorylated
tyrosine or serine. In our experiments with NDRG2DST, no
additional effect on the current amplitude of GluK2 was
observed following coexpression of SGK1. This observation
suggests that the additional phosphorylation of S332 and
T348 does not contribute to the suppressive effect of NDRG2.
Experiments with NDRG2TAV and NDRG2VDD confirmed the
assumption that only the first SGK1 phosphorylation site of
NDRG2, T330, is essential for the suppression of increased
membrane expression of GluK2. Thus, it can be concluded
that only a T330-phosphorylated NDRG2 intervenes in a
concentration-dependent manner in the SGK1-activated
signaling pathway and prevents the increase of membrane
expression of GluK2 in heterologous expression (Figure 8). In
summary, phosphorylation of NDRG2 occurs parallel to the
SGK1-dependent increase of GluK2 membrane expression, and
phosphorylated NDRG2 suppresses the stimulation of GluK2
by SGK1.
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FIGURE 5 | Immunocytochemical detection of GluK2, SGK1, and NDRG2 in rat hippocampal astrocytes. Fluorescence microscopic recordings of
dissociated rat hippocampal astrocytes. Astrocytes are indicated by GFAP antigenicity (red). GluK2 (A, green), SGK1 (B, green) and NDRG2 (C, green) are
colocalized with GFAP-labeled astrocytes. Nuclei were stained with DAPI (blue). Scale bars indicate 20 µm.
Prior studies revealed NDRG2 as a modulator of the
epithelial sodium channel ENaC (Wielpütz et al., 2007) and
the Na+/K+-ATPase (Li et al., 2011). In case of ENaC,
coexpression with NDRG2 leads to an increase in ENaC-
mediated sodium current due to an increased membrane
expression in Xenopus oocytes. Since ENaC is also potentiated
by SGK1, experiments in which all three cRNAs were injected
into oocytes were also performed (Wielpütz et al., 2007),
and both the current as well as the membrane expression
of ENaC were examined. In case of ENaC the mechanism
of potentiation by SGK1 was already clarified (Zhou and
Snyder, 2005). Briefly, SGK1 phosphorylates the ubiquitin
protein ligase Nedd4-2 and thus prevents the ubiquitinylation
of the channel, resulting in increased membrane expression and
consequently increased current amplitude of ENaC (Zhou and
Snyder, 2005; Wielpütz et al., 2007). Another mechanism of
potentiation of ENaC by SGK1 is the direct phosphorylation
of the epithelial Na+ channel (Diakov and Korbmacher,
2004). The mechanism by which NDRG2 contributes to the
potentiation of ENaC remains unexplained. Since GluK2 is
not directly phosphorylated by SGK1 or regulated by Nedd4-2,
it is quite possible that GluK2 is regulated by another
signaling cascade in which NDRG2 plays an opposite role
than in the case of ENaC and thus leads to a suppression
of the SGK1 effect. For example, it is known that GluK2
is directly phosphorylated by protein kinase C and then
sumoylated, with the result that the endocytosis of the kainate
receptor is initiated (Chamberlain et al., 2012). However, to
date no involvement of NDRG2 has been reported in these
processes.
Modulation of GluK2 Membrane Expression in
Primary Astrocytes of Rat Hippocampus by
SGK1 and NDRG2
The expression of the three proteins of interest in astrocytes was
investigated by examination of colocalization of the respective
protein with GFAP in immunocytochemical staining. The
staining of GFAP leads to clearly stained fibrous structures,
which are characteristic for this protein. The detection of GluK2
at the protein level in astrocytes also showed distinct staining.
GluK2 is localized both in the cytosol and at the membrane,
consistent with previous reports (Brand-Schieber et al., 2004).
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FIGURE 6 | Western blot demonstrating regulation of NDRG2 and SGK1 by siRNA and dexamethasone. (A,B) Western blot of cytosolic NDRG2 (A) and
SGK1 (B) expression levels in astrocyte enriched cultures after transfection of control siRNA or siRNA against NDRG2. As control, only transfection reagent was used
(siRNA). Calnexin was used as control protein. The relative band intensities of NDRG2 and SGK1 are summarized to the right of the Western blot images (n = 2–3).
(C–E) Western blot of cytosolic SGK1 (C,D) and NDRG2 (E) expression levels in astrocyte enriched cultures after transfection of control siRNA and siRNA against
NDRG2 and treatment with dexamethasone for 12 h. As control, DMSO was used. Calnexin was used as control protein. The relative band intensities of SGK1 and
NDRG2 are summarized to the right of the Western blot images (n = 2–3). Significant differences are indicated by ∗p < 0.05, ∗∗∗p < 0.001, n.s. = not significant.
Furthermore, the expression of NDRG2 in astrocytes was verified
(Nichols, 2003; Okuda et al., 2008; Shen et al., 2008). Thus, the
published results could be confirmed with respect to protein
expression of NDRG2 in astrocytes. The expression of SGK1 in
astrocytes is currently under discussion. Two reports did not
detect SGK1 in astrocytes (Wärntges et al., 2002; Wu et al., 2013)
whereas two other studies did (Stichel et al., 2005; Slezak et al.,
2013). Here, we could prove the expression of SGK1 protein
in astrocytes by showing colocalization of GFAP and SGK1 in
immunocytochemical staining.
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FIGURE 7 | Dexamethasone alters the GluK2 fluorescence intensity at the astrocyte membrane. (A) Immunocytochemical staining of an astrocyte (GFAP
red, DAPI blue). The light blue line identifies the location of the fluorescence profile. Scale bar = 10 µm. (B,C) GluK2 was immunocytochemically stained in astrocytes
and fluorescence images taken with the Zeiss Observer.Z1 with ApoTome and a 63× oil immersion objective. Exemplary GluK2 fluorescence profiles of astrocytes
without treatment with dexamethasone (Dexa) (B) and with treatment with 1 µM dexamethasone for 12 h (C). (D–G) GluK2 fluorescence profile of the
siRNA-transfected astrocytes (black: siRNA-control, red: siRNA-NDRG2) without dexamethasone treatment (D) and with treatment with 1 µM dexamethasone for
20 min (E), 12 h (F), and 20 h (G). (H) Influence of the siRNA as well as dexamethasone treatment on the regression coefficients of the established regression line.
Changes in the slope of the normalized signal intensity within the first micrometer of the transfected astrocytes when treated with 1 µM dexamethasone for different
durations. GFAP and GluK2 were immunocytochemically stained in astrocytes and fluorescence images taken with the Zeiss Observer.Z1 with ApoTome and 63× oil
immersion objective. Fluorescence profiles were generated in the GluK2 fluorescence channel, and normalized to the highest value of the signal intensity. Then
regression lines were created within the first micrometer of the cell, their slopes were averaged and are shown in diagram (H). ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001, n = 33–48.
To investigate the influence of SGK1 and/or NDRG2
on GluK2 membrane expression in primary astrocytes
of the hippocampus, cell culture conditions providing
different levels of these proteins had to be studied. The
transfection of the siRNA against NDRG2 led to a substantial
reduction in the expression of this protein. Furthermore,
the expression of SGK1 protein was increased by usage of
dexamethasone in the cell culture medium. The observed
increase in the level of SGK1 expression is consistent
with experiments that have been performed in different
secondary cell cultures (Webster et al., 1993; Ullrich et al.,
2005). Notably, it could also be shown in Western blot
experiments that dexamethasone had a stimulating effect
not only on SGK1 but on the protein expression level
of NDRG2 after transfection of the siRNA scrambled
control, consistent with findings by Takahashi et al.
(2011). Inhibition of NDRG2 expression by siRNA against
NDRG2 effectively reduced the protein level of NDRG2 and
abrogated the increase of NDRG2 protein abundance by
dexamethasone.
Physiological Significance of the Suppression of
the SGK1-Mediated Increase in Membrane
Expression of GluK2 by NDRG2 in Astrocytes
According to the present study NDRG2 suppressed the SGK1-
mediated increase in membrane expression of GluK2 in
astrocytes. Thus, the SGK1-mediated incorporation of the
receptor in the membrane of astrocytes is reduced. NDRG2
and SGK1 sensitive regulation of GluK2 protein abundance
could be of importance in various processes. For example, in
cells under stress NDRG2 could prevent an inappropriately
large incorporation of GluK2 receptors by engaging the SGK1-
mediated signaling pathway, thereby reducing the increased
membrane expression. A very high membrane expression
of GluK2 in astrocytes could have a strong influence on
gliotransmission and for instance, impact on the increase
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FIGURE 8 | Regulation of GluK2 by SGK1 and NDRG2. SGK1 activates a
signaling cascade that leads to the increase in membrane expression of
GluK2. Further, SGK1 phosphorylates NDRG2 at phosphorylation site T330,
which leads to an inhibition of the mentioned signaling cascade.
in the intracellular Ca2+ concentration following Ca2+ entry
through the kainate receptor. Activation of GluK receptors in
astrocytes may influence gene expression (McNaughton and
Hunt, 1992). If NDRG2 is overexpressed, cell proliferation
is inhibited (Takeichi et al., 2011; Li et al., 2013). In case
of overexpression of NDRG2, the SGK1-mediated increase in
membrane expression could be suppressed effectively. Thus,
less GluK2 channels would be activated in the astrocyte
membrane and this may have an influence on the gene
expression of the cell. If NDRG2 is down-regulated at
the cellular protein level, cell proliferation is stimulated
(Liu et al., 2011; Takeichi et al., 2011) and more GluK2
receptors could incorporate into the astrocyte membrane
and affect gene expression. Overexpression of NDRG2 in
astrocytes could also have negative effects. In the case of
overexpression of NDRG2, the SGK1-mediated increase in
membrane expression would be suppressed and the number
of GluK2 receptors would be reduced, which may compromise
exocytosis of tPA. Casse et al. (2012) showed that GluK
receptors in astrocytes have an important metabotropic action,
resulting in a signaling cascade that inhibits the exocytosis
of tPA. tPA can bind to and stimulate NMDA receptors
(Nicole et al., 2001). If in a stressful situation there would
be too few kainate receptors at the astrocyte membrane
because of an overexpression of NDRG2, the exocytosis
of tPA could not be prevented and over-excitation of
neighboring neurons could occur via tPA-enhanced NMDAR
function.
In summary, in this study we identify a novel, self-limiting
feedback mechanism that allows for prevention of excessive
SGK1-mediated GluK2 membrane expression following stress
signals.
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